Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12984317 | 0.90 | THRB (0.42) | THRBTSHRALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL28977190 | 0.85 | THRB (0.53) | THRBTSHRALDH1A1CYP2D6CYP2C19 | |
| Ethylene Glycol SCHEMBL2696754 | 0.84 | THRB (0.38) | THRBTSHRALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL3807932 | 0.82 | TSHR (0.59) | THRBTSHRALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL10621006 | 0.82 | HCAR2 (0.41) | THRBTSHRALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL15074980 | 0.82 | THRB (0.59) | THRBTSHRALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL284255 | 0.82 | THRB (0.59) | THRBTSHRALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL5187340 | 0.82 | THRB (0.64) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL7535767 | 0.82 | HCAR2 (0.41) | THRBTSHRALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL15055177 | 0.81 | THRB (0.55) | THRBTSHRALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116782436-A | Silver nanowire heating element and preparation method and application thereof | 浙江大华技术股份有限公司 | 2023-09-19 | — | — | CN | disclosed |
| US-9248216-B2 | Medical devices for delivery of therapeutic agents | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-20130164348-A1 | MEDICAL DEVICES FOR DELIVERY OF THERAPEUTIC AGENTS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| US-8361143-B2 | Medical devices for delivery of therapeutic agents | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-8211455-B2 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-07-03 | — | — | US | disclosed |
| US-20110123594-A1 | Implantable or Insertable Medical Devices For Controlled Delivery of a Therapeutic Agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-05-26 | — | — | US | disclosed |
| US-7939094-B2 | Comprises implantable/insertable implants (catheter, stents) | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-05-10 | — | — | US | disclosed |
| US-7923509-B2 | Drug delivery compositions and medical devices containing block copolymer | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-04-12 | — | — | US | disclosed |
| US-7901702-B2 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-03-08 | — | — | US | disclosed |
| US-20100092540-A1 | DRUG DELIVERY COMPOSITIONS AND MEDICAL DEVICES CONTAINING BLOCK COPOLYMER | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2010-04-15 | — | — | US | disclosed |
| US-20030228346-A1 | Sustained release of superoxide dismutase mimics from implantable or insertable medical devices | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-11 | — | — | US | disclosed |
| WO-2003090806-A1 | MODULATION OF THERAPEUTIC AGENT RELEASE FROM A POLYMERIC CARRIER USING SOLVENT-BASED TECHNIQUES | SCIMED LIFE SYSTEMS, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| US-20030203000-A1 | Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques | BOSTON SCIENTIFIC SCIMED, INC. | 2003-10-30 | — | — | US | disclosed |
| US-20030171496-A1 | Drug delivery compositions and medical devices containing block copolymer | PINCHUK LEONARD (US) | 2003-09-11 | — | — | US | disclosed |
| EP-1341565-A2 | DRUG DELIVERY COMPOSITIONS AND COATED MEDICAL DEVICES | Boston Scientific Limited (BB) | 2003-09-10 | — | — | EP | disclosed |
| WO-2003061718-A2 | MEDICAL ARTICLES HAVING ENZYMATIC SURFACES FOR LOCALIZED THERAPY | SCIMED LIFE SYSTEMS, INC. (US) | 2003-07-31 | — | — | WO | disclosed |
| US-20030138415-A1 | Medical articles having enzymatic surfaces for localized therapy | BOSTON SCIENTIFIC SCIMED, INC. | 2003-07-24 | — | — | US | disclosed |
| US-6545097-B2 | Biocompatible block copolymer comprising one or more elastomeric blocks and one or more thermoplastic blocks connected by a seed polymer | SCIMED LIFE SYSTEMS, INC. | 2003-04-08 | — | — | US | disclosed |
| US-20020107330-A1 | Drug delivery compositions and medical devices containing block copolymer | BOSTON SCIENTIFIC SCIMED, INC. | 2002-08-08 | — | — | US | disclosed |
| WO-2002047731-A2 | DRUG DELIVERY COMPOSITIONS AND COATED MEDICAL DEVICES | SCIMED LIFE SYSTEMS, INC. (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100092540-A1 | DRUG DELIVERY COMPOSITIONS AND MEDICAL DEVICES CONTAINING BLOCK COPOLYMER | VEGFA, VMA21, ABCB1 | THRB 487/4885TSHR 3134/4885ALDH1A1 2756/4885 |
| US-20030203000-A1 | Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques | ABCB11, LPXN, LIPA | THRB 2666/4885TSHR 1872/4885ALDH1A1 3437/4885 |
| US-20030228346-A1 | Sustained release of superoxide dismutase mimics from implantable or insertable medical devices | SOD1, SOD3, CAT | THRB 3358/4885TSHR 3220/4885ALDH1A1 284/4885 |
| US-20030138415-A1 | Medical articles having enzymatic surfaces for localized therapy | CYP21A2, CYP17A1, MGAM | THRB 2797/4885TSHR 2347/4885ALDH1A1 1420/4885 |
| US-20110123594-A1 | Implantable or Insertable Medical Devices For Controlled Delivery of a Therapeutic Agent | MIF, PAICS, IDUA | THRB 1955/4885TSHR 2108/4885ALDH1A1 1259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.